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The binding characteristics of  [3Hlnitrobenzylthioinosine ([3H]NBI) to rat brain membrane  prepara- 
tions was examined, and the autoradiographic distribution of this ligand in brain sections was compared 
with the immunohistochemical  localization of  adenosine deaminase (ADA). It was found that [3HINBI 
labels sites for which adenosine has far higher affinity than do other nucleosides, that these sites are 
heterogeneously distributed and that there is an exact correspondence between areas containing [~H]NBI 
sites and ADA-immunoreact ive  neurons.  Our results indicate that [3H]NBI and ADA are potential 
markers for revealing anatomical sites at which actions of  adenosine may be expressed. 
There is a growing concensus that adenosine is fundamentally involved in inter- 
neuronal communication in the central nervous system [7, 11, 20, 23, 24]. A major 
issue is whether distinct neural systems exist which preferentially release adenosine. 
Currently, the localization of adenosine receptors [13, 14] and their associated 
adenylate cyclases [9, 12, 26] has been the only means available to define brain struc- 
tures and neuronal pathways whose function may be selectively influenced by 
adenosine. In order to identify possible neuronal release sites of adenosine, we have 
focused on the processes of  adenosine reuptake and metabolism since these are 
typical presynaptic functions of  other neurotransmitters [10]. Adenosine uptake 
sites in the rat brain were examined using the well established nucleoside transport 
inhibitor, nitrobenzylthioinosine (NBI) [4, 15, 28], and the distribution of these sites 
was correlated with that of  neurons containing the enzyme, adenosine deaminase 
(ADA) [19]. 
All experiments were performed using adult male Sprague-Dawley rats. For 
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[3H]NBI binding studies using membrane preparations, whole brains (minus the 
cerebellum and brain stem) were homogenized in 50 mM Tris-HC1 buffer, pH 7.4 
(Tris buffer) using a Polytron set at medium speed. The homogenate was centrifug- 
ed at 30,000 g, and the resultant membrane pellet was twice more resuspended by 
homogenization in Tris buffer and centrifuged. The final membrane pellet was 
resuspended in Tris buffer to a final concentration of  1.5-2.0 mg protein/ml as 
determined by the method of Lowry et al. [16] using bovine serum albumin (BSA) 
as standard. [3H]NB1 binding was conducted in a final volume of 1.0 ml of Tris buf- 
fer containing 0.6 nM [3H]NBI (16 Ci/mmol;  Moravek Biochemicals, Brea, CA, 
U.S.A.), 150-200 ~g of membrane proteins in the absence (total binding) or 
presence of 5 /,M NBI (non-specific binding). Incubations were conducted for 15 
min at 24°C and terminated by rapid filtration through Whatman GF/B filters. The 
filters were washed twice with ice-cold Tris buffer, placed in vials containing 10 ml 
of scintillation fluid (ACS; Amersham) and counted in a scintillation counter. 
For immunohistochemical analysis, tissues were processed following transcardiac 
perfusion with 4% paraformaldehyde containing 0.1 M sodium phosphate buffer, 
pH 7.4. Free floating frozen microtome sections were incubated with antibody to 
ADA for 48 h at 4°C in a solution containing 0.9% NaCl, 0.1 M sodium phosphate 
buffer (pH 7.4) and 0.3% Triton X-100. Sections including those serving as primary 
antibody absorption controls, were processed using the peroxidase-anti-peroxidase 
(PAP) method as previously described [19]. 
For [3H]NBI autoradiography, unfixed cryostat sections were collected on cold 
gelatinized slides. The sections were washed twice in 50 mM Tris-HCl buffer (pH 
7.4) for 15 rain, incubated with 1 nM [3H]NBI for 20 min at 25°C, washed twice 
for 5 rain in the same buffer without [3H]NBI and dried overnight at 4°C. The sec- 
lions were exposed for 3 weeks to Ultrofilm which was then developed with Kodak 
D-76 developer and printed on Agfa-Gevaert No. 6 paper giving the final ap- 
pearance of a dark-field photomicrograph. 
Specific [3H]NBI binding to brain membranes was saturable, reversible, reached 
equilibrium within 2 min and typically represented 85% of total binding (see legend 
to Fig. 1 ). In agreement with previous reports [18, 21], computer analysis of the data 
indicated that [3H]NBI binds to a single class of sites with Ka and B ...... values of 
0.06 nM and 147 fmol/mg protein, respectively. As shown in Fig. 1, adenosine 
displaced [3H]NB1 binding with a potency 50-330 times greater than the other 
nucleosides tested. The affinities of the nucleosides (expressed as K~ values 
calculated from ICso data, #M) for the [3H]NBI site were: adenosine, 3.0; inosine, 
164; thymidine, 245; uridine, 391; guanosine, 464; and cytidine, 1000. These Ki 
values agree favorably with the Km (1-5 #M) of adenosine uptake into CNS tissues 
and the Ki (100-300/,M) with which other nucleosides inhibit this uptake [2, 25]. 
In contrast, the K,,, for nucleoside transport into peripheral tissues is in the range 
of  100 IzM for adenosine and 100-300 ixM for the other nucleosides [22]. These find- 
ings together with evidence that [3H]NBI binding sites are present only on cells with 
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Fig. 1. Displacement of [3H]NBI binding to rat brain membranes by various nucleosides. Displacement 
curves for the nucleosides adenosine (#), inosine (©), thymidine (A), uridine (v), guanosine (e), and 
cytidine (D) were constructed using 8-10 concentrations of these agents. IC5o values were calculated on 
the basis of percent of control binding levels which was determined as that amount of [3H]NBI binding 
displaceable by 5 t~M NBI. All samples were assayed in duplicate, and these results are representative of 
experiments performed at least twice with similar results. 
with functional nucleoside transport  sites, indicate with reasonable certainty that 
[3H]NBI labels a physiologically relevant, high-affinity nucleoside transport  system 
in rat brain. However,  this system in brain, with its preference for adenosine, ap- 
pears to exhibit a more restricted substrate specificity compared to peripheral 
tissues. This is the likely basis for the greater affinity and selectivity of  [aH]NBI for 
what appears to be primarily an adenosine transporter in CNS tissue. 
The autoradiographic localization of [3H]NBI binding sites in two brain regions, 
the superior colliculus and hypothalamus,  is shown in Fig. 2. In the superior col- 
liculus, the highest density of  sites was found in its most superficial layer, the 
stratum griseum superficiale (SGS) (Fig. 2c). Substantially less [3H]NBI labeling was 
found in the overlying cortex, the inferior colliculus (ic) and deeper collicular layers. 
In the hypothalamus (Fig. 2d), the heaviest accumulation of  silver grain occurred 
in its posterior basal portion in a band immediately flanking the mammil lary 
nucleus (ran) both anteriorly and posteriorly. These qualitative results are in agree- 
ment with quantitative determinations of  the regional distribution of  [3H]NBI sites 
in the CNS where, of  the 30 discrete areas we examined, the superior colliculus and 
hypothalamus exhibited among the highest levels of  [3H]NBI binding sites (data not 
shown). Fig. 2e shows a tissue section similar to that in Fig. 2c but incubated with 
[3H]NBI in the presence of 5 #M unlabelled NBI. The low level of  background 
labelling is consistent with the high proportion of specific binding obtained using 
membrane  preparations. 
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Fig. 2. Parasaginal  sections of rat brain showing the distribution of neurons stained im- 
munohistochemically for the enzyme adenosine deaminase (ADA) (A, B) and the auloradiographic 
localization and 3H-nitrobenzyhhioinosine ([3H]NBI) binding sites (C, D). Note the close correspondence 
between areas containing the greatest concentration of ADA-immunoreact ive  neural elements and the 
highest density of  autoradiographic silver grains. These areas include the superficial layers of  the superior 
colliculus (so) (arrows) and hypolhalamic regions surrounding the mammillary nucleus (ran) (arrows). 
Non-specific binding of [~H]NBI (shown in E) was determined in adjacent sections incubated with 
[~H]NBI in the presence of 5 ,aM non-radiolabeled NBI. The level of non-specific binding thus obtained 
was similar to areas on the glass slides devoid of tissue. Scale bars: A, 500 `am; B-E shown in D = 500 `am. 
That the binding of  [3H]NBI to sites in tissue homogenates  and sections collected 
on slides represent the same sites was confirmed by comparing the kinetics of  
[3H]NBI binding in the two preparations. Following incubation of  sections in a 
manner identical to that used for whole brain membrane homogenates  and 
autoradiographic studies, the sections were scraped from glass slides for scintillation 
counting. Scatchard analysis gave Ka and B .. . .  values of  0.16 nM and 126 f m o l / m g  
protein, respectively, which agree favorably with the above values observed in whole 
brain homogenates .  
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The distribution of [3H]NBI sites in brain was compared with the location of 
neurons previously described to have high levels of  the enzyme ADA as 
demonstrated immunohistochemically [19] using specific antibody to purified ADA 
[6]. Fig. 2a shows that ADA-immunoreact ive neurons in the superior colliculus are 
concentrated in a zone straddling the deep portion of SGS and the subjacent col- 
licular layer, the stratum opticum. A few ADA-containing neurons, however, can 
be seen scattered throughout SGS. In the hypothalamus,  just anterior to the mam- 
millary nucleus, ADA-immunoreact ive neurons and their processes were located in 
a narrow transverse plane which in the parasagittal section shown in Fig. 2b is seen 
as a band of ADA-positive cells. ADA-containing neurons are also distributed in 
a region posterior to mn. 
These results show that in the superior colliculus and hypothalamus there is an 
exact coincidence of the location of  ADA-rich neurons with areas exhibiting the 
highest density of  [3H]NBI binding sites. However, it is clear from our more exten- 
sive regional analysis that this correlation extends beyond these two structures and 
the parykarya of ADA-rich neurons. For example, the SGS of the superior col- 
liculus and several other CNS structures contained dense networks of  ADA- 
immunoreactive axons and correspondingly high levels of  [3H]NBI sites. In some 
cases ADA-containing fiber pathways were seen clearly delineated in 
autoradiographs by their high levels of  [3H]NBI sites. These results strongly suggest 
that the cell bodies, axons and terminals of  ADA-rich neurons contain an abun- 
dance of [3H]NBI sites. 
It is apparent from several observations that reuptake and catabolism may be im- 
portant  regulatory events governing the bioavailability of  adenosine at its receptor. 
Blockers of  adenosine uptake and inhibitors of  ADA potentiate the sedative and an- 
tinociceptive actions of  adenosine and its stable analogues in animals [5, 27] and the 
inhibitory effects of  adenosine on neuronal electrical activity in the CNS [20]. These 
findings together with the existence of central neurons rich in both ADA and 
adenosine uptake sites suggest a relationship between these neurons and the 
neuronal source of calcium-dependent adenosine release which has been 
demonstrated in vitro [3, 8, 17] and in vivo [1]. It is reasonable to propose that 
neurons which have a high capacity to accumulate and metabolize adenosine may 
also exhibit the greatest propensity to release this substance. In support of  this 
possibility, it is compelling to draw an analogy with other small molecule putative 
neurotransmitter agents which are contained in and released from neurons having 
high synthetic, degradative and reuptake capabilities for their transmitter. If  ADA 
and [3H]NBI are associated with sites at which adenosine is released then (1) these 
may be valuable markers  in locating structural units for studying the actions of  
adenosine at the synaptic level and (2) the present results would suggest that 
adenosine release in the CNS is not a ubiquitous phenomenon but rather may be 
restricted to specific pathways. 
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